S2Medical AB Cash Flow Reinvestment Rate
S2Medical AB cash flow reinvestment rate. S2Medical AB (S2M) has a Cash Flow Reinvestment Rate of 3.03x as of June 2026, reinvesting Skr512.00K (capex Skr512.00K ) from operating cash flow of Skr169.00K. See financial flexibility index of S2Medical AB to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of S2Medical AB (2024–2025)
Cash flow reinvestment rate of S2Medical AB from 2024 to 2025. Historical reinvestment intensity for S2Medical AB across 2 annual periods. Explore S2Medical AB debt service capacity to assess how comfortably operating cash covers total debt obligations.
S2Medical AB Cash Flow Reinvestment Rate by Year (2024–2025)
S2Medical AB cash flow reinvestment rate by year from 2024 to 2025. Year-by-year capital reinvestment analysis for S2Medical AB. For the full cash flow conversion analysis, see S2M cash flow metrics.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.00x | Skr675.00K | Skr675.00K | Skr675.00K | ▲ +296.8% |
| 2024 | 0.25x | Skr1.27 Million | Skr5.03 Million | Skr634.00K | — |